Skip to main content
. 2021 May 13;21:543. doi: 10.1186/s12885-021-08292-8

Fig. 1.

Fig. 1

The adjusted relative risk of SMs, the estimated number of excess cancers and the attributable risk associated with RAI treatment by the site of SMs. The RR was adjusted with age at DTC diagnosis, gender, year of DTC diagnosis and tumor stage